Skip to main content
. 2021 Jun 28;78(8):972–981. doi: 10.1001/jamaneurol.2021.1910

Table 1. Demographics and Baseline Characteristics.

Characteristic Standard of care Home healtha
Age
Participants, No. 19 23
Mean (SD), y 64.1 (10.0) 65.0 (10.9)
Sex, No. (%)
Male 11 (58) 13 (57)
Female 8 (42) 10 (43)
Time since Parkinson disease diagnosis
Participants, No. 19 23
Mean (SD), y 11.5 (7.2) 12.0 (5.9)
Race, No. (%)
White 19 (100) 21 (91)
African American 0 2 (9)
Ethnicity, No. (%)
Hispanic or Latino 1 (5) 3 (13)
Not Hispanic or Latino 18 (95) 20 (87)
Deep brain stimulation target, No. (%)
Subthalamic nucleus 3 (16) 5 (22)
Globus pallidus internus 16 (84) 18 (78)
No. of deep brain stimulation leads, No. (%)
Unilateral 11 (58) 12 (52)
Bilateral 8 (42) 11 (48)
Total UPDRS off-medication scoreb
Participants, No. 18 23
Mean (SD) 46.8 (14.0) 60.1 (20.3)
Off-levodopa/on-levodopa responsec
Participants, No. 19 23
Mean (SD), % 31.0 (24.0) 37.0 (21.0)
UPDRS III off-medication scorec
Participants, No. 19 23
Mean (SD) 33.5 (9.4) 40.5 (12.9)
UPDRS III on-medication scorec
Participants, No. 19 23
Mean (SD) 23.2 (10.9) 25.3 (11.9)
PDQ-39 score
Participants, No. 18 23
Mean (SD) 21.2 (22.5) 33.6 (21.2)
Levodopa equivalent daily dose, mg
Participants, No. 11 14
Mean (SD) 1104.0 (579.7) 1174.6 (612.7)
Caregivers enrolled, No. (%) 14 (74) 22 (96)
Multidimensional Caregiver Strain Index score
Participants, No. 12 21
Mean (SD) 12.7 (13.8) 16.1 (12.6)

Abbreviations: PDQ-39, 39-question Parkinson’s Disease Questionnaire; UPDRS, Unified Parkinson’s Disease Rating Scale; UPDRS III, Unified Parkinson’s Disease Rating Scale part III.

a

Patients in the home health arm had slightly more parkinsonism, as indicated by the higher mean total UPDRS and UPDRS III off-medication scores.

b

The total UPDRS is the sum of parts I, II, III, and IV.

c

Preoperative baseline used.